{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:10:17Z","timestamp":1748578217398,"version":"3.41.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01 HL138172"],"award-info":[{"award-number":["K01 HL138172"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["PaCR-2017C2-8153"],"award-info":[{"award-number":["PaCR-2017C2-8153"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ahjo.2022.100112","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T17:35:41Z","timestamp":1646242541000},"page":"100112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab"],"prefix":"10.1016","volume":"13","author":[{"given":"Steven M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj A.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta G.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester Kim","family":"Nilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanna M.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine G.","family":"Derington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia H.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravani","family":"Chandaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lav Parshottambhai","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McClay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Priest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kruti","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Viera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelaine","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Pletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda M.","family":"Cooper-DeHoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7807","key":"10.1016\/j.ahjo.2022.100112_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ahjo.2022.100112_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ahjo.2022.100112_bb0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin\u2013angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.ahjo.2022.100112_bb0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ahjo.2022.100112_bb0025","article-title":"Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with\/without hypertension","author":"Yu","year":"2021","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.ahjo.2022.100112_bb0030","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/jcm10122642","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers withdrawal is associated with higher mortality in hospitalized patients with COVID-19","volume":"10","author":"Roy-Vallejo","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ahjo.2022.100112_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2021.100088","article-title":"COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system","volume":"9","author":"An","year":"2021","journal-title":"Int. J. Cardiol. Hypertens."},{"issue":"8","key":"10.1016\/j.ahjo.2022.100112_bb0040","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/HJH.0000000000002866","article-title":"Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease","volume":"39","author":"Tse","year":"2021","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.ahjo.2022.100112_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/HJH.0000000000002706","article-title":"Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor\/angiotensin II receptor blocker use during COVID-19: beyond confounding","volume":"39","author":"Cohen","year":"2021","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.ahjo.2022.100112_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248080","article-title":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. den Uil C, ed","volume":"16","author":"Derington","year":"2021","journal-title":"PLoS ONE"},{"issue":"20","key":"10.1016\/j.ahjo.2022.100112_bb0055","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahjo.2022.100112_bb0060","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockade on renal angiotensin-(1\u20137) forming enzymes and receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ahjo.2022.100112_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006115","article-title":"The PCORnet blood pressure control laboratory","volume":"13","author":"Pletcher","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"21","key":"10.1016\/j.ahjo.2022.100112_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022224","article-title":"Tracking blood pressure control performance and process metrics in 25 US health systems: the PCORnet blood pressure control laboratory","volume":"10","author":"Cooper-DeHoff","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"24","key":"10.1016\/j.ahjo.2022.100112_bb0075","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2020.20323","article-title":"Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations","volume":"324","author":"Kadri","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahjo.2022.100112_bb0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Stat. Med."},{"issue":"10229","key":"10.1016\/j.ahjo.2022.100112_bb0085","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ahjo.2022.100112_bb0090","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"7821","key":"10.1016\/j.ahjo.2022.100112_bb0095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ahjo.2022.100112_bb0100","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCRESAHA.121.318054","article-title":"Hypertension, a moving target in COVID-19","volume":"128","author":"Savoia","year":"2021","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ahjo.2022.100112_bb0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J. Card. Fail."},{"issue":"4","key":"10.1016\/j.ahjo.2022.100112_bb0110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/HJH.0000000000002784","article-title":"Renin\u2013angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies","volume":"39","author":"Bavishi","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ahjo.2022.100112_bb0115","article-title":"Renin\u2013angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis","author":"MMY","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"3","key":"10.1016\/j.ahjo.2022.100112_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ahjo.2022.100112_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100962","article-title":"Telmisartan for treatment of Covid-19 patients: an open multicenter randomized clinical trial","volume":"37","author":"Duarte","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.ahjo.2022.100112_bb0130","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am. J. Epidemiol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602222000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602222000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:46:27Z","timestamp":1748547987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602222000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"alternative-id":["S2666602222000295"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2022.100112","relation":{},"ISSN":["2666-6022"],"issn-type":[{"type":"print","value":"2666-6022"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2022.100112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100112"}}